Toshiyuki Hayashi

Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin

Toshiyuki Hayashi, Tomoyasu Fukui, Noriko Nakanishi et al. · Cardiovascular Diabetology · 2017 · 200 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Relationship between daily and day-to-day glycemic variability and increased oxidative stress in type 2 diabetes

Makoto Ohara, Tomoyasu Fukui, Motoshi Ouchi et al. · Diabetes Research and Clinical Practice · 2016 · 107 citations · Full text

Medicine, Endocrinology, Diabetology +16

Hybrid Monte Carlo-diffusion method for light propagation in tissue with a low-scattering region

Toshiyuki Hayashi, Yoshihiko Kashio, Eiji Okada · Applied Optics · 2003 · 96 citations

Engineering, Biomedical Engineering, Neuroscience +17

Dapagliflozin Influences Ventricular Hemodynamics and Exercise-Induced Pulmonary Hypertension in Type 2 Diabetes Patients　― A Randomized Controlled Trial ―

Hiroyuki Kayano, Shinji Koba, Tsutomu Hirano et al. · Circulation Journal · 2020 · 61 citations · Full text

Medicine, Cardiology, Pharmacology +17

Listerial invasion protein internalin B promotes entry into ileal Peyer's patches in vivo

Sayuri Chiba, Takeshi Nagai, Toshiyuki Hayashi et al. · Microbiology and Immunology · 2010 · 60 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +14